Nisa Investment Advisors
ATXI

Nisa Investment Advisors’s Avenue Therapeutics, Inc. Common Stock ATXI Stock Holding History

Nisa Investment Advisors’s Portfolio ATXI Stock Details ATXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-17
Closed -$207K – 2368
2020
Q3 		$207K Buy
+17
New +$207K ﹤0.01% 1295

Other funds holding ATXI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BRWA
B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nisa Investment Advisors's ATXI Position: Q4 2020 in Review

Nisa Investment Advisors sold out of Avenue Therapeutics, Inc. Common Stock (ATXI) in Q4 2020, closing a stake of 17 shares — an estimated $207K sold.

Nisa Investment Advisors first reported a position in ATXI in Q3 2020 and held it in 1 quarter. The position peaked at $207K in Q3 2020. 33 funds tracked by Wall St. Rank hold ATXI as of Q4 2020.

  • Nisa Investment Advisors reported no remaining Avenue Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Nisa Investment Advisors sold 17 Avenue Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $207K.
  • Nisa Investment Advisors first reported a position in Avenue Therapeutics, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Nisa Investment Advisors's Avenue Therapeutics, Inc. Common Stock position peaked at $207K in Q3 2020.
  • 33 funds tracked by Wall St. Rank held Avenue Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.